ARK Genomic Revolution ETF (BATS:ARKG) Stock Price Crosses Above 50 Day Moving Average – Here’s Why

ARK Genomic Revolution ETF (BATS:ARKG)’s share price passed above its 50 day moving average during trading on Tuesday. The stock has a 50 day moving average of $49.46 and traded as high as $51.99. ARK Genomic Revolution ETF shares last traded at $51.65, with a volume of 6,004,095 shares changing hands.

ARK Genomic Revolution ETF Price Performance

The company has a 50-day simple moving average of $49.46 and a 200 day simple moving average of $37.03.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in ARKG. Canal Insurance CO bought a new stake in ARK Genomic Revolution ETF during the 3rd quarter valued at about $6,517,000. Gimbal Financial purchased a new stake in ARK Genomic Revolution ETF in the 3rd quarter valued at about $6,478,000. Himension Capital Singapore PTE. LTD. purchased a new stake in ARK Genomic Revolution ETF in the 1st quarter valued at about $2,250,000. Client First Investment Management LLC bought a new position in ARK Genomic Revolution ETF in the 2nd quarter worth about $2,579,000. Finally, Turner Financial Group Inc. bought a new position in ARK Genomic Revolution ETF in the 2nd quarter worth about $1,633,000.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.